147 related articles for article (PubMed ID: 34246718)
1. Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model.
Brandão SR; Reis-Mendes A; Domingues P; Duarte JA; Bastos ML; Carvalho F; Ferreira R; Costa VM
Toxicology; 2021 Jul; 459():152852. PubMed ID: 34246718
[TBL] [Abstract][Full Text] [Related]
2. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract][Full Text] [Related]
3. Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Brito V; Morás AM; Henriques JAP; Saffi J
Toxicol In Vitro; 2018 Oct; 52():203-213. PubMed ID: 29913208
[TBL] [Abstract][Full Text] [Related]
4. Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment.
Zhao Y; Miriyala S; Miao L; Mitov M; Schnell D; Dhar SK; Cai J; Klein JB; Sultana R; Butterfield DA; Vore M; Batinic-Haberle I; Bondada S; St Clair DK
Free Radic Biol Med; 2014 Jul; 72():55-65. PubMed ID: 24632380
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
6. Effects of Doxorubicin and Fenofibrate on the activities of NADH oxidase and citrate synthase in mice.
Yao CX; Li WY; Zhang SF; Zhang SF; Zhang HF; Zang MX
Basic Clin Pharmacol Toxicol; 2011 Dec; 109(6):452-6. PubMed ID: 21711451
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial cumulative damage induced by mitoxantrone: late onset cardiac energetic impairment.
Rossato LG; Costa VM; Dallegrave E; Arbo M; Silva R; Ferreira R; Amado F; Dinis-Oliveira RJ; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
Cardiovasc Toxicol; 2014 Mar; 14(1):30-40. PubMed ID: 24096626
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
9. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction.
Berthiaume JM; Oliveira PJ; Fariss MW; Wallace KB
Cardiovasc Toxicol; 2005; 5(3):257-67. PubMed ID: 16244371
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.
Cui L; Guo J; Zhang Q; Yin J; Li J; Zhou W; Zhang T; Yuan H; Zhao J; Zhang L; Carmichael PL; Peng S
Toxicol Lett; 2017 Jun; 275():28-38. PubMed ID: 28456571
[TBL] [Abstract][Full Text] [Related]
11. Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.
Dhingra R; Guberman M; Rabinovich-Nikitin I; Gerstein J; Margulets V; Gang H; Madden N; Thliveris J; Kirshenbaum LA
Cardiovasc Res; 2020 May; 116(6):1161-1174. PubMed ID: 31566215
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice.
Brandão SR; Reis-Mendes A; Duarte-Araújo M; Neuparth MJ; Rocha H; Carvalho F; Ferreira R; Costa VM
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371499
[TBL] [Abstract][Full Text] [Related]
13. Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling.
Dhingra R; Margulets V; Chowdhury SR; Thliveris J; Jassal D; Fernyhough P; Dorn GW; Kirshenbaum LA
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5537-44. PubMed ID: 25489073
[TBL] [Abstract][Full Text] [Related]
14. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Reis-Mendes A; Gomes AS; Carvalho RA; Carvalho F; Remião F; Pinto M; Bastos ML; Sousa E; Costa VM
Arch Toxicol; 2017 Apr; 91(4):1871-1890. PubMed ID: 27629428
[TBL] [Abstract][Full Text] [Related]
15. Early Cardiac Mitochondrial Molecular and Functional Responses to Acute Anthracycline Treatment in Wistar Rats.
Pereira GC; Pereira SP; Pereira FB; Lourenço N; Lumini JA; Pereira CV; Bjork JA; Magalhães J; Ascensão A; Wieckowski MR; Moreno AJ; Wallace KB; Oliveira PJ
Toxicol Sci; 2019 May; 169(1):137-150. PubMed ID: 30698778
[TBL] [Abstract][Full Text] [Related]
16. The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.
Dores-Sousa JL; Duarte JA; Seabra V; Bastos Mde L; Carvalho F; Costa VM
Toxicology; 2015 Mar; 329():106-19. PubMed ID: 25582955
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.
Santos DL; Moreno AJ; Leino RL; Froberg MK; Wallace KB
Toxicol Appl Pharmacol; 2002 Dec; 185(3):218-27. PubMed ID: 12498738
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
[TBL] [Abstract][Full Text] [Related]
19. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations.
Costa VM; Capela JP; Sousa JR; Eleutério RP; Rodrigues PRS; Dores-Sousa JL; Carvalho RA; Lourdes Bastos M; Duarte JA; Remião F; Almeida MG; Varner KJ; Carvalho F
Arch Toxicol; 2020 Dec; 94(12):4067-4084. PubMed ID: 32894303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
